Dongsheng Tu
机构: Professor of Biostatistics, Queen's University at Kingston, Canada
每年引用次数
引用次数
引用: 50,542
H-指数: 84
I10-指数 : 235
出版物: 544
The economic impact of the transition from branded to generic oncology drugs.
Winson Y. Cheung , Nicole Mittmann , Natasha B. Leighl , Matthew C. Cheung
Journal of Clinical Oncology 34 6520 -6520
2016
Hypertension and beta-blocker use as prognostic and predictive factors in metastatic colorectal cancer: A retrospective analysis of NCIC CTG CO.17.
Shelly Sud , Christopher J O'Callaghan , Christos Stelios Karapetis , Caleb Jonker
Journal of Clinical Oncology 34
2016
The CCTG CO.26 trial: A phase II randomized study of durvalumab plustremelimumab and best supportive care (BSC) vs BSC alone in patients with advanced colorectal carcinoma (CRC) refractory to standard therapies.
Eric Xueyu Chen , Derek J. Jonker , Hagen F. Kennecke , Sheryl L. Koski
Journal of Clinical Oncology 35
4
2017
The CCTG PA.7 trial: A randomized phase II study of gemcitabine and nab-paclitaxel vs. gemcitabine, nab-paclitaxel, durvalumab, and tremelimumab as 1st line therapy in metastatic pancreatic ductal adenocarcinoma (PDAC).
Daniel John Renouf , Petr Kavan , Neesha C Dhani , Derek J Jonker
Journal of Clinical Oncology 35
1
2017
Phase I study of oncolytic virus (OV) MG1 maraba/MAGE-A3 (MG1MA3), with and without transgenic MAGE-A3 adenovirus vaccine (AdMA3) in incurable advanced/metastatic MAGE-A3-expressing solid tumours: CCTG IND.214.
Derek J. Jonker , Sebastien J. Hotte , Albiruni Ryan Abdul Razak , Daniel John Renouf
Journal of Clinical Oncology 35
5
2017
A Phase III Randomized, Double-Blind, Placebo-Controlled Study Evaluating Dextromethorphan Plus Slow-Release Morphine for Chronic Cancer Pain Relief in Terminally Ill Patients
Deborah J. Dudgeon , Eduardo Bruera , Bruno Gagnon , Sharon M. Watanabe
Journal of Pain and Symptom Management 33 ( 4) 365 -371
25
2007
Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials
Divine E. Ediebah , Chantal Quinten , Corneel Coens , Jolie Ringash
Cancer 124 ( 16) 3409 -3416
27
2018
A threshold linear mixed model for identification of treatment-sensitive subsets in a clinical trial based on longitudinal outcomes and a continuous covariate.
Xinyi Ge , Yingwei Peng , Dongsheng Tu
Statistical Methods in Medical Research 29 ( 10) 2919 -2931
2020
Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer
Helen J. Mackay , Elizabeth A. Eisenhauer , Suzanne Kamel-Reid , Ming Tsao
Cancer 120 ( 4) 603 -610
49
2014
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.
Jolie Ringash , Heather-Jane Au , Lillian L. Siu , Jeremy D. Shapiro
Cancer 120 ( 2) 181 -189
14
2014
Abstract P2-11-03: Predictive significance of an optimized immunohistochemical panel for basal-like breast cancer on the CCTG MA.12 phase III randomized clinical trial
Vivien H Bramwell , Dongsheng Tu , Lois E Shepherd , Torsten O Nielsen
Cancer Research 80
2020
Multiply robust subgroup identification for longitudinal data with dropouts via median regression
Wenqi Lu , Guoyou Qin , Zhongyi Zhu , Dongsheng Tu
Journal of Multivariate Analysis 181 104691
2021
Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17
Paul E. Goss , James N. Ingle , Silvana Martino , Nicholas J. Robert
Journal of Clinical Oncology 25 ( 15) 2006 -2011
119
2007
Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
Andrea Bezjak , Dongsheng Tu , Lesley Seymour , Gary Clark
Journal of Clinical Oncology 24 ( 24) 3831 -3837
265
2006
Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
Kim N. Chi , Sebastien J. Hotte , Evan Y. Yu , Dongsheng Tu
Journal of Clinical Oncology 28 ( 27) 4247 -4254
213
2010
The prognostic effects of somatic mutations in ER-positive breast cancer.
Obi L. Griffith , Nicholas C. Spies , Meenakshi Anurag , Malachi Griffith
Nature Communications 9 ( 1) 3476 -3476
38
2018
Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials
Benjamin Djulbegovic , Ambuj Kumar , Branko Miladinovic , Tea Reljic
PLoS ONE 8 ( 3) e58711
27
2013
Recent Development in the Joint Modeling of Longitudinal Quality of Life Measurements and Survival Data from Cancer Clinical Trials
Hui Song , Yingwei Peng , Dongsheng Tu
Advanced Statistical Methods in Data Science 153 -168
3
2016
CONSTRUCTING NONPARAMETRIC LIKELIHOOD CONFIDENCE REGIONS WITH HIGH ORDER PRECISIONS
Xiao Li , Jiahua Chen , Yaohua Wu , Dongsheng Tu
Statistica Sinica 21 ( 4)
5
2011
Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer
Simron Singh , Wendy Parulekar , Nevin Murray , Ronald Feld
Journal of Clinical Oncology 23 ( 4) 850 -856
79
2005
Lois Shepherd Lesley Seymour Kathleen I. Pritchard C Karapetis John Zalcberg Jeremy Shapiro Timothy Price Christopher J O'Callaghan Michael Brundage Wendy R. Parulekar Ian Gilron John Goffin Lillian Siu Ronald R. Holden Nancy E Davidson Penelope Bradbury Stephen KL Chia Zee Chung-Ying Benny Ming Tsao Sharlene Gill